发明申请
US20120100521A1 Microfluidic Isolation of Tumor Cells or Other Rare Cells from Whole Blood or Other Liquids
审中-公开
来自全血或其他液体的肿瘤细胞或其他罕见细胞的微流控分离
- 专利标题: Microfluidic Isolation of Tumor Cells or Other Rare Cells from Whole Blood or Other Liquids
- 专利标题(中): 来自全血或其他液体的肿瘤细胞或其他罕见细胞的微流控分离
-
申请号: US12992225申请日: 2009-05-13
-
公开(公告)号: US20120100521A1公开(公告)日: 2012-04-26
- 发明人: Steven A. Soper , Michael C. Murphy , June Feng , Robin L. McCarley , André A. Adams
- 申请人: Steven A. Soper , Michael C. Murphy , June Feng , Robin L. McCarley , André A. Adams
- 国际申请: PCT/US2009/043697 WO 20090513
- 主分类号: C12N5/078
- IPC分类号: C12N5/078 ; B01L99/00 ; C12Q1/06 ; C12M1/34 ; C12N5/09
摘要:
Microdevices are disclosed to efficiently, accurately, and rapidly isolate and enumerate rare cells, such as circulating tumor cells, from liquids such as whole blood. The system employs multiple parallel meandering channels having a width on the order of 1-2 cell diameters. The microdevices can be produced at low-cost, may readily be automated, and in many instances may be used without pre-processing of the sample. They may be used to isolate and enumerate rare cells, including for example the detection and diagnosis of cancers, cancer staging, or evaluating the effectiveness of a therapeutic intervention, or detecting pathogenic bacteria. The device may optionally be used to nondestructively capture and later to release target cells.
公开/授权文献
信息查询